Skip to content

Mulderrig v. Amyris, Inc., et al., Case No. 4:19-cv-01765-YGR (N.D. Cal.)

A securities class action against a biopharmaceutical company and certain of its officers for alleged misrepresentations concerning the company’s recognized and projected revenues. After extensive briefing and a hearing for which Ms. Murphy presented argument on behalf of plaintiffs, the class action complaint survived defendants’ motion to dismiss in its entirety, despite the heightened fraud and PSRLA pleading standards. Ms. Murphy spearheaded the aggressive prosecution of the case, including the issuance of several discovery requests and subpoenas duces tecum as well as the review of hundreds of thousands of documents. Ms. Murphy also successfully briefed and presented oral argument in support of plaintiffs’ motion for class certification. Shortly following the court’s order certifying a nationwide class, the parties settled the action for a common fund of $13.5 million.